SCHEMBL19325989

SCHEMBL19325989

NOCCNC(=O)c1cccc(Cl)c1O

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.54
▸ RAB9A P51151 5/20 0.54
▸ KLKB1 P03952 1/20 0.50
▸ PLAU P00749 2/20 0.47
▸ PLAT P00750 2/20 0.47
▸ P2RX7 Q99572 2/20 0.47
▸ F2 P00734 1/20 0.47
▸ F10 P00742 1/20 0.47
▸ P2RX1 P51575 1/20 0.47
▸ P2RX4 Q99571 1/20 0.47
▸ TMPRSS4 Q9NRS4 1/20 0.47
▸ HPGD P15428 3/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ ALOX5 P09917 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.44
▸ POLB P06746 2/20 0.43
▸ TAS1R3 Q7RTX0 1/20 0.43
▸ TAS1R1 Q7RTX1 1/20 0.43
▸ TAS1R2 Q8TE23 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19325533 0.81 AKR1C4 (0.47) HPGDALDH1A1POLB
SCHEMBL23067401 0.78 ALOX5 (0.45) NPC1RAB9AHPGDSMN1; SMN2ALOX5
SCHEMBL3607272 0.77 KLKB1 (0.61) KLKB1PLAUPLATP2RX7F2
SCHEMBL28763778 0.76 HPGD (0.53) NPC1RAB9AKLKB1PLAUPLAT
SCHEMBL19326233 0.75 CDK1 (0.65) P2RX7P2RX1P2RX4TMPRSS4
SCHEMBL4408502 0.74 ALOX5 (0.59) NPC1RAB9AHPGDALOX5ALDH1A1
SCHEMBL8288031 0.73 NPC1 (0.70) NPC1RAB9AHPGDSMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL11575167 0.72 ALDH1A1 (0.60) RAB9AHPGDSMN1; SMN2ALDH1A1POLB
SCHEMBL16456496 0.71 ALOX5 (0.56) NPC1RAB9AKLKB1HPGDALOX5
SCHEMBL17748294 0.70 ALOX5 (0.68) HPGDALOX5ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170253607-A1 LONG-ACTING HIV PROTEASE INHIBITOR SHIONOGI & CO., LTD. (JP) 2017-09-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170253607-A1 LONG-ACTING HIV PROTEASE INHIBITOR CPN1, HAT1, PRSS1 NPC1 1693/4885RAB9A 4095/4885KLKB1 3919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback